Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The company also serves dental laboratories, government and institutional health care clinics and other alternate care sites. The company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of branded products and Henry Schein private-brand products in stock.
Industry sector: Medical
Sector classification: Medical & hospital equipment
Deep Learning based analysis and prediction model for Henry Schein, Inc. (HSIC) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Oct. 2, 2015.
Market data for HSIC model training are being downloaded from the Quandl premium datasets on a daily basis.
Model is being retrained on a daily basis.
|% Held by Insiders||1.15%|
|% Held by Institutions||96.49%|
|EPS (last reported FY)||$3.60|
|EPS (last reported Q)||$0.97|
|EPS, estimated (last reported Q)||$0.97|
|Total revenues||$12 B|
|Net income||$0 B|